+86-27-65522453 sales@sun-shinechem.com

AZD1208

Catalog No.: 51702
Cas No.: 1204144-28-4
Purity : 98% by HPLC/HNMR 
51702 - AZD1208 | CAS 1204144-28-4

Catalog number : 51702

CAS number : 1204144-28-4

分子式 : C21H21N3O2S 

分子量 : 379.48 

Iupac 化学名称 : (5Z)-5-[[2-[(3R)-3-amino-1-piperidinyl][1,1'-biphenyl]-3-yl]methylene]-2,4-thiazolidinedione 

Smile : N[C@H]1CN(CCC1)C1=C(C=CC=C1\C=C/1\C(NC(S1)=O)=O)C1=CC=CC=C1

InChiKey : MCUJKPPARUPFJM-UWCCDQBKSA-N

PackagingPriceAvailabilityPurityEstimated Shipping Time
BulkEnquiryEnquiry
Request Bulk Quote Download MSDS电话:+86-27-59253327 | Email:sales@sun-shinechem.com
同义词AZD1208;AZ-1208 
英文同义词AZD1208;AZ-1208 
分子式C21H21N3O2S 
分子量379.48 
外观light-yellow solid to off-white solid 
纯度98% by HPLC/HNMR 
可溶性2mg/ml in DMSO 
存储3 years -20ºCpowder 
运输条件Shipped under ambient temperature. 
SmileN[C@H]1CN(CCC1)C1=C(C=CC=C1\C=C/1\C(NC(S1)=O)=O)C1=CC=CC=C1
InChiKeyMCUJKPPARUPFJM-UWCCDQBKSA-N
InChiInChI=1S/C21H21N3O2S/c22-16-9-5-11-24(13-16)19-15(12-18-20(25)23-21(26)27-18)8-4-10-17(19)14-6-2-1-3-7-14/h1-4,6-8,10,12,16H,5,9,11,13,22H2,(H,23,25,26)/b18-12-/t16-/m1/s1
Coming soon.

AZD1208 is a potent, highly selective, and orally available Pim kinase inhibitor that effectively inhibits all three isoforms at<5 nM or <150 nM in enzyme and cell assays, respectively. AZD1208 inhibited the growth of 5 of 14 acute myeloid leukemia (AML) cell lines tested, and sensitivity correlates with Pim-1 expression and STAT5 activation. AZD1208 causes cell cycle arrest and apoptosis in MOLM-16 cells, accompanied by a dose-dependent reduction in phosphorylation of Bcl-2 antagonist of cell death, 4EBP1, p70S6K, and S6, as well as increases in cleaved caspase 3 and p27. Inhibition of p4EBP1 and p-p70S6K and suppression of translation are the most representative effects of Pim inhibition in sensitive AML cell lines. AZD1208 inhibits the growth of MOLM-16 and KG-1a xenograft tumors in vivo with a clear pharmacodynamic-pharmacokinetic relationship. AZD1208 also potently inhibits colony growth and Pim signaling substrates in primary AML cells from bone marrow that are Flt3 wild-type or Flt3 internal tandem duplication mutant.

 

Other Related Products

1204144-28-4 - Request Bulk Quote

×
1204144-28-4 - Request Bulk Quote
Change